FBLGFibroBiologics, Inc.同业对比
FibroBiologics, Inc. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FBLG本股 | $6M#8 | 0.3x#2 | 1.4x#11 | — | — | -67.1%#12 | — | -402.2%#12 | -1409.7%#6 | — | -87.7%#2 | — |
| TOVX | $8M#1 | 0.1x#1 | 0.1x#1 | — | -100.0%#6 | 7.5%#7 | — | -42.1%#6 | -51.4%#1 | — | — | — |
| SNGX | $8M#2 | — | 1.2x#10 | 64.9x#5 | -85.8%#5 | -33.7%#10 | -9923.2%#5 | -167.0%#9 | — | 5#1 | -76.6%#1 | — |
| TPST | $7M#4 | — | — | 25.1x#4 | -54.8%#4 | 37.2%#5 | -9008.5%#4 | — | — | — | — | — |
| CNSP | $7M#5 | — | 0.4x#4 | — | — | -7.6%#9 | — | -0.1%#3 | — | — | — | — |
| SYBX | $7M#6 | — | 0.6x#6 | — | -100.0%#6 | 95.7%#1 | — | -8.4%#4 | — | — | — | — |
| KPRX | $7M#7 | — | 0.4x#5 | — | -100.0%#6 | -401.4%#14 | — | -0.1%#2 | -127.6%#3 | — | — | — |
| VTGN | $7M#3 | — | 0.3x#3 | 5.9x#3 | 161.1%#1 | -35.5%#11 | -5683.7%#3 | -284.7%#11 | -949.7%#5 | — | — | — |
| ENVB | $6M#10 | — | 0.8x#8 | 0.2x#1 | -7.2%#3 | 26.0%#6 | -22.0%#1 | 149.7%#1 | -100.4%#2 | 3#2 | — | — |
| XCUR | $6M#9 | — | 6.6x#13 | — | -100.0%#6 | 49.0%#2 | — | -506.2%#13 | — | — | — | — |
| APRE | $6M#11 | — | 0.2x#2 | — | — | 2.8%#8 | — | -32.8%#5 | — | — | — | — |
| ALZN | $6M#12 | — | 1.1x#9 | — | — | -94.3%#13 | — | -151.2%#8 | — | — | — | — |
| ACXP | $5M#13 | — | 0.7x#7 | — | — | 43.5%#4 | — | -97.7%#7 | — | — | — | — |
| PULM | $5M#14 | — | 2.1x#12 | 0.7x#2 | 7.0%#2 | 46.0%#3 | -66.2%#2 | -201.9%#10 | -235.7%#4 | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-02。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议